Chronic pulmonary aspergillosis
Also known as: CPA, Chronic pulmonary Aspergillus infection, Chronic cavitary pulmonary aspergillosis, Chronic fibrosing pulmonary aspergillosis
Chronic pulmonary aspergillosis (CPA) is a persistent fungal infection typically complicating pre-existing structural lung pathology, such as post-tuberculous cavitation. Clinical presentation includes productive cough, fatigue, dyspnoea, unintentional weight loss, and haemoptysis; specialist respiratory evaluation is mandatory for disease management. The cited evidence comprises case reports and observational studies pertaining to malignancy, immunosuppression, persistent cavities, and haemorrhagic complications. No evidence currently demonstrates that acupuncture or Chinese herbal medicine (CHM) is effective in improving or treating CPA. Standard medical management, including antifungal pharmacotherapy when indicated and clinical monitoring, remains the primary intervention. Traditional Chinese Medicine (TCM) frameworks are provided solely for individualised adjunctive symptom support in stable cohorts and do not constitute validated disease subtypes or alternatives to conventional antifungal therapy.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Utilise professional smoking cessation services and strictly avoid exposure to tobacco smoke and environmental respiratory irritants.
- •Maintain regular dietary intake and monitor body mass weekly; seek dietetic consultation if unintentional weight loss persists.
- •Adhere to a balance of rest and gentle, paced physical activity as dictated by the respiratory team; cease activity immediately upon onset of haemoptysis, thoracic pain, or significant dyspnoea.
- •Attend all scheduled antifungal monitoring, diagnostic imaging, and laboratory assessments; maintain a comprehensive record of all prescribed pharmaceuticals and supplements.
Cautions & Contraindications
- •Defer elective acupuncture and herbal initiation during active haemoptysis or clinical instability pending medical assessment. This is a conservative precaution informed by the bleeding context in the supplied study, not a studied acupuncture contraindication.[]
- •Do not replace, interrupt or independently adjust antifungal, oncology or immunosuppressive treatment. Patients with malignancy or immunosuppression need coordination with their treating specialists; the supplied case reports do not establish herbal safety or interactions.[,]
- •Do not treat persistent post-tuberculosis cough or residual cavities solely as a TCM pattern. Respiratory reassessment is required because the supplied observational study associates CPA with cavity persistence, without proving causation or TCM benefit.[]
When to reassess or seek care again
If medically stable and adjunctive care is agreed, review after 2–4 weeks using cough severity on a 0–10 scale, sputum burden, sleep disruption, weight and ability to perform usual activities. Stop or revise adjunctive treatment if there is no meaningful benefit or any adverse effect. New bleeding, fever, weight loss or worsening breathlessness triggers earlier medical review, not completion of a treatment course. Imaging, microbiology and antifungal monitoring remain specialist-led.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- BMC infectious diseases · 2026
- Medicine · 2025
- Experimental and therapeutic medicine · 2026
- Frontiers in medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
